Here, a dual‐gating strategy combining locally delivered borate glass (BG) and ultrasound (US) is developed for the precise and effective inhibition of breast cancer by targeting transient receptor potential vanilloid 2 (TRPV2). The gene discussed is TRPV2; the disease is breast carcinoma.